VIP会员
激肽释放酶抑制剂肽
作用
| 中文名称 | 激肽释放酶抑制剂肽 |
|---|---|
| 中文同义词 | 激肽释放酶抑制剂肽;GALNAC-NAG37 亚磷酰胺单体 |
| 英文名称 | L-Glutamamide, N2-[[cis-4-[[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]oxy]cyclohexyl]carbonyl]-N-[2-[2-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]-L-α-glutaminyl-N1,N5-bis[2-[2-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]- |
| 英文同义词 | L-Glutamamide, N2-[[cis-4-[[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]oxy]cyclohexyl]carbonyl]-N-[2-[2-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]-L-α-glutaminyl-N1,N5-bis[2-[2-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]-;L-Glutamamide, N2-[[cis-4-[[[bis(1-methylethyl)amino](2-cyanoethoxy)phosphino]oxy]cyclohexyl]carbonyl]-N-[2-[2-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethoxy]ethyl]-L-α-glutaminyl-N1,N5-bis[2-[2-[[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]oxy]ethox...;(2R,3R,4R,5R,6R)-5-acetamido-6-[2-[2-[[(4S)-5-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydropyran-2-yl]oxyethoxy]ethylamino]-4-[[(4S)-5-[2-[2-[(2R,3R,4R,5R,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydropyran-2-yl]oxyethoxy]ethylamino]-4-[[4-[2-cyanoethoxy-(diisopropylamino)phosphanyl]oxycyclohexanecarbonyl]amino]-5-oxo-pentanoyl]amino]-5-oxo-pentanoyl]amino]ethoxy]ethoxy]-3,4-diacetoxy-tetrahydropyran-2-yl]methyl acetate;NAG37 Phosphoramidite;NAG 37 |
| CAS号 | 2199491-27-3 |
| 分子式 | C80H127N10O37P |
| 分子量 | 1851.88 |
| EINECS号 | |
| 相关类别 | |
| Mol文件 | Mol File |
| 结构式 |
激肽释放酶抑制剂肽 性质
| 沸点 | 1541.0±65.0 °C(Predicted) |
|---|---|
| 酸度系数(pKa) | 13.56±0.70(Predicted) |
激肽释放酶抑制剂肽 用途与合成方法
作用
激肽释放酶抑制剂肽通过降低血浆激肽释放酶的活性发挥作用，用于HAE患者，预防和治疗血管水肿发作。
粤公网安备44196802000105号
400-6226-992